BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8613355)

  • 21. Development of a mucosal complex vaccine against oral Salmonella infection in mice.
    Harada H; Nishikawa F; Higashi N; Kita E
    Microbiol Immunol; 2002; 46(12):891-905. PubMed ID: 12597365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
    Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
    Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.
    Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H
    J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 is an effective adjuvant for induction of mucosal immunity.
    Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
    J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
    Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
    Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
    Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
    J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
    Wilson AD; Bailey M; Williams NA; Stokes CR
    Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization with F4 fimbriae and CpG formulated with carboxymethyl starch enhances F4-specific mucosal immune response and modulates Th1 and Th2 cytokines in weaned pigs.
    Delisle B; Calinescu C; Mateescu MA; Fairbrother JM; Nadeau É
    J Pharm Pharm Sci; 2012; 15(5):642-56. PubMed ID: 23331903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract.
    McGhee JR; Xu-Amano J; Miller CJ; Jackson RJ; Fujihashi K; Staats HF; Kiyono H
    Reprod Fertil Dev; 1994; 6(3):369-79. PubMed ID: 7831485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
    Boyaka PN; Marinaro M; Jackson RJ; van Ginkel FW; Cormet-Boyaka E; Kirk KL; Kensil CR; McGhee JR
    J Immunol; 2001 Feb; 166(4):2283-90. PubMed ID: 11160283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
    Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
    Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
    Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
    Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation.
    Kjerrulf M; Grdic D; Kopf M; Lycke N
    Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.